Otsuka Pharmaceutical Co., Ltd.

This study is testing a new foam medication called OPA-15406 to see if it can better control eczema symptoms in children compared to a placebo foam. It will involve about 200 children with moderate eczema, measuring how well their skin clears after 4 weeks of treatment. A smaller…

This study is testing if a new foam containing the drug OPA-15406 is better than a foam without the drug at improving skin in adults with moderate atopic dermatitis (eczema). About 156 participants will apply the foam to their skin for 4 weeks. The main goal is to see if the acti…